Login
$BCTX
$3.30 -$0.09 (2.65%) Live

Company Executives

Officer Age In this role Source
William V. Williams Also a director
President, Chief Executive Officer and Director
71 Not stated
Gadi Levin
Chief Financial Officer and Corporate Secretary
54 Since 2016
10 years
Giuseppe Del Priore
Chief Medical Officer
65 Since 2022
4 years
Miguel A. Lopez Lago
Chief Scientific Officer
56 Since 2022
4 years

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
6
serving now
Independent
5 of 6
stated in the proxy
Average tenure
6.8 years
from year joined
CEO also chairs the board
No
Jamieson Bondarenko
Director Age On board Independent Committees Other public boards Pay Source
Jamieson Bondarenko
41 2019
7 years
Independent None stated None stated Not stated
William V. Williams
70 2016
10 years
Not independent None stated None stated Paid as CEO
Jane Gross
69 2022
4 years
Independent
Audit Committee Compensation Committee
aTyr Pharmaceuticals Not stated
Rebecca Taub
73 2019
7 years
Independent
Nominating and Corporate Governance Committee
None stated Not stated
Vaughn C. Embro-Pantalony
68 2019
7 years
Independent
Compensation Committee
Microbix Biosystems Inc. Not stated
Martin Schmieg
63 2020
6 years
Independent
Compensation Committee · Chair
None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Feb 12, 2026
former director (not named)
former director
$332.25 per share
2024

Sale to a former director of 6,019 common shares (post-consolidation) together with warrants to purchase up to 6,019 common shares, at a combined purchase price of $332.25 per share and accompanying warrant

Chief Executive Officer (not named)
Chief Executive Officer
$350,000
2025

Grant of 5,833 RSUs to the CEO as compensation for deferred salary, with immediate vesting, offsetting previously accrued compensation owed to the CEO

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support